MUHAMMAD DOGAR: Open Payments
NPI 1851312649 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,402 in 43 payments from 14 companies in 2025. Trend: 2023 $1,095 · 2024 $1,099 · 2025 $1,402
Food & beverage: $1,402
| Company | Payments | Amount |
|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 9 | $277 |
| Kestra Medical Technology Services, Inc. | 2 | $177 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $141 |
| Phathom Pharmaceuticals, Inc. | 10 | $137 |
| Abbott Laboratories | 1 | $131 |
| ABIOMED | 1 | $125 |
| SCPHARMACEUTICALS INC. | 4 | $111 |
| AstraZeneca Pharmaceuticals LP | 2 | $82 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $50 |
Products named: LifeVest, Assure WCD, Kerendia, VOQUEZNA, AVEIR, FUROSCIX, VERQUVO, JARDIANCE.
Industry payments across NY — which companies pay providers there.
